BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Applied Data Research Release: Cardiovascular Stent Technology Evolving to Address Therapeutic Shortfall


5/6/2008 1:27:52 PM

(Nashua, NH) - The introduction of the drug eluting stent (DES) has been a significant development in cardiology, revolutionizing treatment for patients and improving outcomes. But as their use has grown, reports of adverse events and potential risk factors have dimmed the luster of first-generation DES and led to a debate within the cardiovascular community that is intense and ongoing.

Efforts to correct perceived weaknesses in the current generation of coated devices has led to an intense level of activity, with more than two dozen technology-driven companies pursuing development-stage stents designed to provide improved patient outcomes by eliminating or at least mitigating the problems of marketed devices. These participants are exploring a number of new and innovative approaches that include novel stent geometries, non-durable stents, new classes of drugs, and novel coating application technologies and strategies. These and other findings of a recent survey are the subject of a comprehensive report. The report documents and analyzes cardiovascular stent development activity and the companies driving the next-generation of stent technology. More information is also available at www.applieddata.org .

About Applied Data Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Contact: Greg Stone Voice: 603-595-6225 www.applieddata.org



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->